Chiasma Inc Quick Ratio (CHMA) starting from the first quarter 2021 to first quarter 2020, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Chiasma Inc   (NASDAQ: CHMA)

Chiasma Inc 's Quick Ratio

CHMA's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the first quarter 2021, Quick Ratio fell to 6.64 below Chiasma Inc average.

Within Major Pharmaceutical Preparations industry 273 other companies have achieved higher Quick Ratio than Chiasma Inc in first quarter 2021. While Quick Ratio total ranking in the first quarter 2021 has deteriorated compared to the prior quarter from 726 to 854.

Explain Quick Ratio?
How much Cash & cash equivalents CHMA´s has?
What are CHMA´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CHMA Quick Ratio (Mar 31 2021)
Q1		 (Dec 31 2020)
Q4		 (Sep 30 2020)
Q3		 (Jun 30 2020)
Q2		 (Mar 31 2020)
Q1
Y / Y Current Liabilities Change 29.21 % 47.09 % 91.05 % 80.33 % -52.45 %
Y / Y Cash & cash equivalent Change 45.13 % 46.6 % 52.64 % 15.37 % 134.11 %
Quick Ratio MRQ 6.64 8.09 8.64 4.21 5.91
CHMA's Total Ranking # 854 # 726 # 436 # 487 # 456
Seq. Current Liabilities Change 3.51 % -7.8 % 13.82 % 18.94 % 17.84 %
Seq. Cash & cash equivalent Change -15.06 % -13.61 % 133.66 % -15.36 % -14.2 %



Quick Ratio first quarter 2021 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 274
Healthcare Sector # 439
Overall Market # 854


Quick Ratio Statistics
High Average Low
30.9 9.79 1.2
(Dec 31 2015)   (Mar 31 2019)




Financial Statements
Chiasma Inc 's Current Liabilities $ 17 Millions Visit CHMA's Balance sheet
Chiasma Inc 's Cash & cash equivalent $ 115 Millions Visit CHMA's Balance sheet
Source of CHMA's Sales Visit CHMA's Sales by Geography


Cumulative Chiasma Inc 's Quick Ratio

CHMA's Quick Ratio for the trailling 12 Months

CHMA Quick Ratio

 (Mar 31 2021)
12 Months		 (Dec 31 2020)
12 Months		 (Sep 30 2020)
12 Months		 (Jun 30 2020)
12 Months		 (Mar 31 2020)
12 Months
Y / Y Current Liabilities TTM Growth 58.03 % 10.91 % -21.67 % -32.58 % -41.6 %
Y / Y Cash & cash equivalent TTM Growth 42.65 % 52.76 % 67.32 % 87.83 % 86.53 %
Quick Ratio TTM 6.96 6.83 6.72 6.8 7.71
Total Ranking TTM # 974 # 808 # 537 # 616 # 658
Seq. Current Liabilities TTM Growth 6.1 % 9.1 % 17.22 % 16.47 % -25.54 %
Seq. Cash & cash equivalent TTM Growth 8.16 % 10.88 % 15.83 % 2.69 % 15.82 %

Quick ratio ranking by company, industry and sector >> Back to CHMA Financial Strength Comparisons >> Go to Compare CHMA Quick Ratio to its Competitors

On the trailing twelve months basis CHMA Cash & cash equivalent soared by 45.13 % in Q1 2021 year on year, faster than Current Liabilities, this led to increase in in Chiasma Inc 's Quick Ratio to 6.96, above CHMA average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 492 other companies have achieved higher Quick Ratio than Chiasma Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the fourth quarter 2020 from 4507 to 4569.

Explain Quick Ratio?
How much Cash & cash equivalents CHMA´s has?
What are CHMA´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 493
Healthcare Sector # 966
Within the Market # 854


trailing twelve months Quick Ratio Statistics
High Average Low
12.41 3.16 0.65
(Dec 31 2015)   (Mar 31 2019)




Companies with similar Quick Ratio in the quarter ending Mar 31 2021, within Major Pharmaceutical Preparations Industry Quick RatioMar 31 2021 MRQ Cash & cash equivalentMar 31 2021 MRQ Current Liabilities
Shattuck Labs Inc   17.94 $ 321.176  Millions$ 17.903  Millions
Atrium Therapeutics Inc   17.58 $ 307.914  Millions$ 17.514  Millions
Marker Therapeutics inc   17.56 $ 64.508  Millions$ 3.674  Millions
Enanta Pharmaceuticals Inc  17.53 $ 375.947  Millions$ 21.443  Millions
Constellation Pharmaceuticals Inc  17.39 $ 382.080  Millions$ 21.975  Millions
Actinium Pharmaceuticals Inc  17.36 $ 72.303  Millions$ 4.164  Millions
Bio Green Med Solution Inc   17.24 $ 47.777  Millions$ 2.772  Millions
Ibio inc   17.13 $ 103.947  Millions$ 6.067  Millions
Prf Technologies Ltd   16.72 $ 16.571  Millions$ 0.991  Millions
Mirati Therapeutics Inc   16.69 $ 1,287.163  Millions$ 77.105  Millions
Arvinas Inc   16.13 $ 651.271  Millions$ 40.372  Millions
Metacrine Inc   16.13 $ 84.457  Millions$ 5.236  Millions
Cymabay Therapeutics Inc   15.86 $ 125.458  Millions$ 7.909  Millions
Tao Synergies Inc   15.84 $ 14.849  Millions$ 0.938  Millions
Bioxcel Therapeutics Inc   15.74 $ 194.015  Millions$ 12.324  Millions
Werewolf Therapeutics Inc   15.64 $ 84.602  Millions$ 5.409  Millions
Intra cellular Therapies Inc   15.41 $ 611.965  Millions$ 39.702  Millions
Gossamer Bio Inc   15.40 $ 453.297  Millions$ 29.444  Millions
Oncolytics Biotech Inc   15.34 $ 31.607  Millions$ 2.060  Millions
Phio Pharmaceuticals Corp  14.92 $ 32.695  Millions$ 2.191  Millions
Connect Biopharma Holdings Limited  14.89 $ 267.716  Millions$ 17.985  Millions
Y mabs Therapeutics inc   14.84 $ 252.271  Millions$ 17.000  Millions
Ayala Pharmaceuticals Inc   14.63 $ 48.110  Millions$ 3.289  Millions
Prothena Corporation Public Limited Company  14.62 $ 342.993  Millions$ 23.456  Millions
Vanda Pharmaceuticals Inc   14.49 $ 378.162  Millions$ 26.105  Millions
Chemomab Therapeutics Ltd   14.41 $ 58.203  Millions$ 4.039  Millions
Dianthus Therapeutics Inc   14.37 $ 132.288  Millions$ 9.206  Millions
Aditxt Inc   14.28 $ 14.045  Millions$ 0.983  Millions
Ovid Therapeutics Inc   14.27 $ 233.202  Millions$ 16.346  Millions
Siga Technologies Inc  14.18 $ 106.527  Millions$ 7.512  Millions

Date modified: 2026-09-08T15:10:15+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.